OncoLens Raises Seed Funding To Streamline Cancer Treatment Planning

(Atlanta) OncoLens, a clinical decision software that focuses on oncology (cancer care), has closed a $1.35 million seed round led by BIP Capital and Atlanta Technology Angels (ATA).  The platform...

Read More +

Measurement and Collection of AONN+ Metrics Within an Automated Tumor Board Workflow

Background: The tumor board is the foundation of high-value multidisciplinary oncology care through coordinating teams of specialists. The nurse navigator is often a central hub of tumor boards, with...

Read More +

Optimal Research and OncoLens Collaborate on Just-In-Time Clinical Trials for Cancer Patients

ROCKVILLE, Md. & TUCKER, Ga., Feb 19, 2018 (BUSINESS WIRE) -- Optimal Research, a patient identification and trial activation service provider, and OncoLens™, a software as a service (SaaS) tumor ...

Read More +